InMed Pharmaceuticals Inc. (FRA:MWG)
Germany
· Delayed Price · Currency is EUR 1.100
+0.020 (1.85%)
At close: Dec 4, 2025
InMed Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
| Net Income | -8.21 | -8.16 | -7.68 | -7.95 | -18.6 | -10.2 | Upgrade
|
| Depreciation & Amortization | 0.55 | 0.53 | 0.6 | 0.6 | 0.51 | 0.23 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 0.01 | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 3.47 | - | Upgrade
|
| Stock-Based Compensation | 0.11 | 0.12 | 0.14 | 0.28 | 0.78 | 0.61 | Upgrade
|
| Provision & Write-off of Bad Debts | 0 | 0 | - | 0.05 | - | - | Upgrade
|
| Other Operating Activities | 0.07 | 0.08 | 0.32 | 0.31 | 1.32 | 0.02 | Upgrade
|
| Change in Accounts Receivable | -0.06 | -0.11 | -0.09 | -0.22 | -0.04 | 0.04 | Upgrade
|
| Change in Inventory | 0.33 | 0.28 | 0.07 | 0.57 | -2 | - | Upgrade
|
| Change in Accounts Payable | 0.12 | -0.25 | 0.05 | -0.81 | -0.81 | 0.35 | Upgrade
|
| Change in Other Net Operating Assets | -0.46 | -0.26 | -0.39 | -0.11 | -0.22 | -0.84 | Upgrade
|
| Operating Cash Flow | -7.55 | -7.77 | -6.99 | -7.28 | -15.58 | -9.79 | Upgrade
|
| Capital Expenditures | - | - | -0.01 | -0.16 | -0.04 | -0 | Upgrade
|
| Cash Acquisitions | - | - | - | -0.5 | -0.21 | - | Upgrade
|
| Investing Cash Flow | - | - | -0.01 | -0.66 | -0.67 | -0 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -0.29 | - | Upgrade
|
| Total Debt Repaid | - | - | - | - | -0.29 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | - | -0.29 | - | Upgrade
|
| Issuance of Common Stock | 12.13 | 13.16 | 5.22 | 10.68 | 17.15 | 12.47 | Upgrade
|
| Other Financing Activities | -0.83 | -0.88 | -0.56 | - | -1.78 | -1.62 | Upgrade
|
| Financing Cash Flow | 11.3 | 12.27 | 4.65 | 10.68 | 15.07 | 10.85 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | - | 0.49 | Upgrade
|
| Net Cash Flow | 3.75 | 4.5 | -2.34 | 2.74 | -1.19 | 1.56 | Upgrade
|
| Free Cash Flow | -7.55 | -7.77 | -7 | -7.45 | -15.62 | -9.79 | Upgrade
|
| Free Cash Flow Margin | -157.31% | -157.14% | -152.14% | -180.02% | -1434.03% | - | Upgrade
|
| Free Cash Flow Per Share | -1.91 | -7.96 | -18.36 | -60.81 | -557.14 | -728.60 | Upgrade
|
| Cash Income Tax Paid | - | - | 0.01 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -3.95 | -4.22 | -4.02 | -4.81 | -8.87 | -5.35 | Upgrade
|
| Unlevered Free Cash Flow | -3.95 | -4.22 | -4.02 | -4.81 | -8.87 | -5.35 | Upgrade
|
| Change in Working Capital | -0.07 | -0.34 | -0.37 | -0.57 | -3.07 | -0.45 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.